LakeShore Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 14, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	33	47	136	149	233	-
Market Cap Growth	-63.60%	-65.52%	-8.94%	-36.18%	-	-
Enterprise Value	84	71	176	408	373	-
Last Close Price	0.77	2.45	7.20	16.00	67.97	-
PS Ratio	0.17	0.55	1.71	1.49	2.94	-
PB Ratio	0.23	0.68	1.67	1.40	2.20	-
P/TBV Ratio	0.52	0.80	1.91	1.57	-	-
EV/Sales Ratio	0.99	0.84	2.22	4.08	4.70	-
Debt / Equity Ratio	0.83	0.83	0.73	0.69	0.57	0.02
Asset Turnover	0.43	0.43	0.36	0.44	0.39	-
Inventory Turnover	0.50	0.50	0.94	0.83	0.90	-
Quick Ratio	0.64	0.64	0.86	1.27	1.23	1.84
Current Ratio	1.02	1.02	1.13	1.57	1.61	2.13
Return on Equity (ROE)	-18.43%	-18.43%	-65.99%	-40.50%	-32.69%	-
Return on Assets (ROA)	-2.15%	-2.15%	-13.85%	-5.17%	-5.46%	-
Return on Capital (ROIC)	-3.22%	-3.22%	-20.01%	-7.17%	-7.71%	-
Earnings Yield	-45.03%	-29.47%	-44.28%	-27.72%	-16.00%	-
FCF Yield	-60.88%	-39.41%	-34.68%	-23.00%	-31.70%	-
Buyback Yield / Dilution	-89.94%	-79.18%	-73.06%	0.07%	-	-

Updated Aug 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q